Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major (Q79449674)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

main subject

beta-thalassemia major

1 reference

1 reference

Nicholas G Angelopoulos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Anastasia Goula

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Eugenia Katounda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Grigorios Rombopoulos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Victoria Kaltzidou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Dimitrios Kaltsas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sophia Malaktari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Vassilis Athanasiou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

George Tolis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Metabolism

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

60-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

Serum osteoprotegerin and receptor activator of nuclear factors kB (RANKL) concentrations in normal children and in children with pubertal precocity, Turner's syndrome and rheumatoid arthritis

23 December 2019

cites work

1 reference

12 December 2020

Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain.

1 reference

12 December 2020

Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines

1 reference

12 December 2020

Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates

1 reference

12 December 2020

New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia

1 reference

12 December 2020

Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status

1 reference

12 December 2020

Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.

1 reference

12 December 2020

Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment

1 reference

12 December 2020

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

1 reference

12 December 2020

Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone

1 reference

12 December 2020

Correlates of osteoprotegerin levels in women and men.

1 reference

12 December 2020

Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?

1 reference

12 December 2020

Circulating levels of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population

1 reference

12 December 2020

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

12 December 2020

Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males

1 reference

12 December 2020

Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells

1 reference

12 December 2020

Osteopontin expression and function: role in bone remodeling

1 reference

12 December 2020

High incidence of osteoporosis in thalassaemia major

1 reference

12 December 2020

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

12 December 2020

Bone metabolism and oxidative stress in postmenopausal rats with iron overload

1 reference

12 December 2020

Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status

1 reference

12 December 2020

1 reference

12 December 2020

Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major.

1 reference

12 December 2020

Osteoprotegerin deficiency and juvenile Paget's disease

1 reference

12 December 2020

Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine.

1 reference

12 December 2020

Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women

1 reference

12 December 2020

Hypogonadism and Hormone Replacement Therapy on Bone Mass of Adult Women with Thalassemia Major

1 reference

12 December 2020

Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.

1 reference

12 December 2020

Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle

1 reference

12 December 2020

High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment

1 reference

12 December 2020

Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75

1 reference

12 December 2020

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

12 December 2020

The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches

1 reference

12 December 2020

The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro

1 reference

12 December 2020

Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.

1 reference

12 December 2020

10.1007/S00774-006-0728-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187195%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference